9th Fragment-based Drug Discovery Meeting

April 2024 — UK

The 9th RSC-BMCS Fragment-based Drug Discovery conference highlighting real-world case studies that have successfully progressed to advanced stages in drug development.

The 9th RSC-BMCS Fragment-based Drug Discovery conference aims to highlight real-world case studies that have successfully progressed to advanced stages in drug development, including late-stage medicinal chemistry and pre-clinical or clinical stages.

Initiated in 2007, the conference will maintain its tradition, dedicating the majority of its presentations to these case studies. These will be augmented by updates on technological advancements in high concentration screening, NMR, SPR, and X-ray methods.

The event is tailored for professionals like chemists, biophysicists, and structural biologists, catering to both seasoned practitioners in the field of fragment-based drug discovery and newcomers eager to explore this dynamic sector.

Attracting a global audience, the conference is a hub for delegates from the UK, across Europe, and other countries including the USA, Japan, China, and South Korea.